LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23rd Annual Healthcare Conference in December 2012. Details are below.
|PRESENTER:||Steve Gilman, EVP and Chief Scientific Officer|
|EVENT:||Oppenheimer 23rd Annual Healthcare Conference|
|DATE:||Thursday, December 13, 2012|
|TIME:||10:35 a.m. Eastern Time|
|LOCATION:||The Waldorf Astoria, New York City|
Live audio with slide webcast can be accessed here.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.